Ascend Wellness Holdings (AAWH) Change in Accured Expenses (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Change in Accured Expenses of $1.9 million for Q1 2026, up 124.36% year-over-year from $863794.3 in Q1 2025, and down 79.15% quarter-over-quarter from $9.3 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Change in Accured Expenses history runs 7 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 124.36% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $10.5 million (up 202.16% YoY), while the FY2025 annual figure was $595000.0, up 134.88% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at $1.9 million, down from $9.3 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $14.2 million in Q4 2023, with the low at -$9.1 million in Q3 2025.
- The 5-year median for Change in Accured Expenses is $605000.0 (2024), against an average of $1.7 million.
- Peak annual rise in Change in Accured Expenses reached 1792.09% in 2025, while the deepest fall reached 1415.04% in 2025.
- Ascend Wellness Holdings' Change in Accured Expenses stood at -$8.0 million in 2022, then jumped by 277.51% to $14.2 million in 2023, then tumbled by 76.26% to $3.4 million in 2024, then soared by 175.6% to $9.3 million in 2025, then sank by 79.15% to $1.9 million in 2026.
- Business Quant data shows AAWH's Change in Accured Expenses at $1.9 million in Q1 2026, $9.3 million in Q4 2025, and -$9.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Ascend Wellness Holdings | 97.42 Mn | 30.42 Mn | 45.49 Mn | 14.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.17 Mn |
| Jun 30, 2026 | 14.17 Mn |
| Mar 31, 2026 | 1.94 Mn |
| Mar 31, 2026 | 1.94 Mn |
| Dec 31, 2025 | 9.30 Mn |
| Dec 31, 2025 | 9.30 Mn |
| Sep 30, 2025 | -9.09 Mn |
| Sep 30, 2025 | -9.09 Mn |
| Jun 30, 2025 | 8.34 Mn |
| Jun 30, 2025 | 8.34 Mn |
| Mar 31, 2025 | -7.96 Mn |
| Mar 31, 2025 | -7.96 Mn |
| Dec 31, 2024 | 3.37 Mn |
| Dec 31, 2024 | 3.37 Mn |
| Sep 30, 2024 | -5.19 Mn |
| Sep 30, 2024 | -5.19 Mn |
| Jun 30, 2024 | -493,000.00 |
| Jun 30, 2024 | -493,000.00 |
| Mar 31, 2024 | 605,000.00 |
| Mar 31, 2024 | 605,000.00 |